The pandemic has had a mixed impact on the healthcare sector since its outbreak more than a year ago, putting the emergency
The worst seems to be over for Boston Scientific. Is the stock a buy?
Categories
Health Care
Two areas that provide Pfizer (PFE) with ample opportunity for future growth
Shares of Pfizer Inc. (NYSE: PFE) have gained over 8% in the past one year. Pfizer is at the forefront of the
Organigram Holdings Inc.(OGI) Q2 2021 Earnings Call Transcript
Organigram Holdings Inc. (NASDAQ: OGI) Q2 2021 earnings call dated Apr. 13, 2021. Corporate Participants: Amy Schwalm -- Vice President, Investor Relations
Aphria Inc. (APHA) Q3 2021 Earnings Call
Aphria Inc. (NASDAQ: APHA) Q3 2021 earnings call dated Apr. 12, 2021 Corporate Participants: Carl Merton — Chief Financial Officer Irwin D. Simon — Chief Executive Officer
It’s worth keeping an eye on Vertex Pharma (VRTX) stock. Here’s why
After dominating the cystic fibrosis market for quite some time, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is currently expanding its clinical programs to
Aphria Inc (APHA) Q3 2021 Earnings Call Transcript
Aphria Inc (NASDAQ: APHA) Q3 2021 earnings call dated Apr. 12, 2021 Corporate Participants: Carl Merton -- Chief Financial Officer Irwin D. Simon -- Chief Executive
With low valuation and solid portfolio, Teladoc can be a good bet for long term
The adoption of telemedicine services accelerated since early last year after coronavirus crippled the healthcare system and threw patient-physician interaction out of
Will restructuring, cost-cutting help Walgreens (WBA) beat COVID blues?
The growing demand for new therapeutic solutions and advanced research in areas like human-genome will keep the biotechnology industry busy in the
Walgreens Boots Alliance Inc. (WBA) Q2 2021 Earnings Call
Walgreens Boots Alliance Inc. (NASDAQ: WBA) Q2 2021 earnings call dated Mar. 31, 2021 Corporate Participants: Gerald Gradwell — Senior Vice President of Investor Relations
AngioDynamics Inc (ANGO) Q3 2021 Earnings Call
AngioDynamics Inc. (NASDAQ: ANGO) Q3 2021 earnings call dated Mar. 30, 2021. Corporate Participants: Jim Clemmer — President and Chief Executive Officer Stephen A. Trowbridge — Executive Vice
Trxade (MEDS) betting big on its new health passport app
With COVID-19 vaccination taking place on a full-fledged scale across the country, the Joe Biden administration had last month announced its commitment
Here’s what you need to know before investing in Amgen (AMGN)
The coronavirus outbreak has made leading pharma companies channelize their resources for vaccine development, and the efforts have been largely successful. While
Walgreens Boots Alliance, Inc. (WBA) Q2 2021 Earnings Call Transcript
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) Q2 2021 earnings call dated Mar. 31, 2021 Corporate Participants: Gerald Gradwell -- Senior Vice President of Investor
Walgreens Boots Alliance (WBA) Earnings: Key financials and quarterly highlights
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported second-quarter 2021 earnings results today. Sales increased 4.6% to $32.8 billion. It is up 3.5%
AngioDynamics Inc (ANGO) Q3 2021 Earnings Call Transcript
AngioDynamics Inc. (NASDAQ: ANGO) Q3 2021 earnings call dated Mar. 30, 2021. Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A. Trowbridge -- Executive
Trxade Group (MEDS) delivers annual revenue growth of 130%
Trxade (NASDAQ: MEDS) on Monday posted a 17% increase in fourth-quarter revenues to $2 million, riding on the strength of the Trxade
Neogen Corp (NEOG) Q3 2021 Earnings Call Transcript
Neogen Corp (NASDAQ: NEOG) Q3 2021 earnings call dated Mar. 23, 2021. Corporate Participants: John Adent -- Chief Executive Officer and President Steve Quinlan -- Chief
With a Phase 2 success, Entera Bio’s pipeline might be worth betting on
Reporting by Arjun Vijay While rising interest in biotechnology has provided a much-needed fillip to the research and development of therapies, one
Entera Bio Ltd. (ENTX) Q4 2020 Earnings Call Transcript
Entera Bio Ltd. (NASDAQ: ENTX) Q4 2020 earnings call dated Mar. 18, 2021 Corporate Participants: Jonathan Lieber -- Chief Financial Officer, U.S.
Cipher Pharmaceuticals Inc. (CPH) Q4 2020 Earnings Call Transcript
Cipher Pharmaceuticals Inc. (TSX: CPH) Q4 2020 earnings call dated Mar. 19, 2021 Corporate Participants: Craig Mull -- Interim Chief Executive Officer Scott Langille -- Chief
What’s happening on the COVID-19 front? Here are a few updates.
Right about this time last year, the COVID-19 pandemic took over the world with full force as several countries went into complete